These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18615191)

  • 1. A survey of insulin-dependent diabetes-part I: therapies and devices.
    Takahashi D; Xiao Y; Hu F; Lewis M
    Int J Telemed Appl; 2008; 2008():405796. PubMed ID: 18615191
    [No Abstract]   [Full Text] [Related]  

  • 2. A survey of insulin-dependent diabetes-part I: therapies and devices.
    Takahashi D; Xiao Y; Hu F; Lewis M
    Int J Telemed Appl; 2008; 2008():639019. PubMed ID: 18437199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Insulin-Dependent Diabetes-Part II: Control Methods.
    Takahashi D; Xiao Y; Hu F
    Int J Telemed Appl; 2008; 2008():739385. PubMed ID: 18566688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
    Snell-Bergeon JK
    Diabetes Technol Ther; 2015 Nov; 17(11):759-62. PubMed ID: 26535926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen.
    Naïditch N; Mauchant C; Benabbad I; Hehn C; Joubert M; Thébaut JF; Rosilio M
    Diabetes Ther; 2023 Feb; 14(2):303-318. PubMed ID: 36422803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey.
    Sze D; Oliveria T
    Clin Diabetes; 2020 Jan; 38(1):56-61. PubMed ID: 31975752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.
    Pauley ME; Tommerdahl KL; Snell-Bergeon JK; Forlenza GP
    Curr Cardiol Rep; 2022 Dec; 24(12):2043-2056. PubMed ID: 36279036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy.
    Marra G;
    Acta Biomed; 2004 Dec; 75(3):164-70. PubMed ID: 15796090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to Uptake of Insulin Technologies and Novel Solutions.
    Pauley ME; Berget C; Messer LH; Forlenza GP
    Med Devices (Auckl); 2021; 14():339-354. PubMed ID: 34803408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in insulin therapy for type 2 diabetes.
    Sorli C
    Am J Med; 2014 Oct; 127(10 Suppl):S39-48. PubMed ID: 25282012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insulin Delivery Recommendations.
    Frid AH; Kreugel G; Grassi G; Halimi S; Hicks D; Hirsch LJ; Smith MJ; Wellhoener R; Bode BW; Hirsch IB; Kalra S; Ji L; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1231-55. PubMed ID: 27594187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-Sectional Pilot Survey of Rural Clinic Attitudes and Proficiency with Insulin Pumps and Continuous Glucose Monitoring Devices.
    Bergloff A; Stratton E; Briggs Early K
    Diabetes Technol Ther; 2019 Nov; 21(11):665-670. PubMed ID: 31339738
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States.
    Grunberger G; Sze D; Ermakova A; Sieradzan R; Oliveria T; Miller EM
    Clin Diabetes; 2020 Jan; 38(1):47-55. PubMed ID: 31975751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review and update of insulin dependent diabetes mellitus.
    Gorrell JJ; Williams JS; Powell P
    J Pediatr Pharmacol Ther; 2003 Oct; 8(4):252-65. PubMed ID: 23118681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact dermatitis in children caused by diabetes devices.
    Alves da Silva C; Bregnhøj A; Mowitz M; Bruze M; Andersen KE; Sommerlund M
    Contact Dermatitis; 2022 Nov; 87(5):406-413. PubMed ID: 35634681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose Effectiveness: The Mouse Trap in the Development of Novel ß-Cell Replacement Therapies.
    Korsgren E; Korsgren O
    Transplantation; 2016 Jan; 100(1):111-5. PubMed ID: 26413992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient perceptions of insulin therapy in diabetes self-management with insulin injection devices.
    Consoli A; Formoso G
    Acta Diabetol; 2023 May; 60(5):705-710. PubMed ID: 36828942
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.